[Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer].
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004064:Digestive System / Q000187:drug effects; D004357:Drug Synergism; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D007275:Injections, Intravenous; D007970:Leukopenia / Q000139:chemically induced; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008207:Lymphatic Metastasis; D008297:Male; D008875:Middle Aged; D011859:Radiography
D000970:Antineoplastic Agents; D006834:Hydrazines; D005472:Fluorouracil
Sperimentazione clinica con procarazina e fluorouracile nel carcinoma polmonare avanzato.